サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1439500

腸管管理システム - 世界市場の考察、競合情勢、市場予測（2030年）

Bowel Management Systems - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日: 受注後更新 | 発行: DelveInsight | ページ情報: 英文 150 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
腸管管理システム - 世界市場の考察、競合情勢、市場予測（2030年）
出版日: 受注後更新
発行: DelveInsight
ページ情報: 英文 150 Pages
納期: 2～10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の腸管管理システムの市場規模は、2023年に14億8,000万米ドル、2030年までに18億7,000万米ドルに達し、2024年～2030年の予測期間にCAGRで3.98％の成長が見込まれます。腸管管理製品に対する需要の増加は主に、腸管関連障害を発症しやすい老年人口が世界中で増加していることに起因しています。さらに、パーキンソン病や脳卒中などの神経疾患の増加、脊髄損傷や外傷などによる神経損傷の増加も、腸管管理システムの需要を増加させます。また、腸管障害の予防と管理に関する意識を高める政府の取り組みの増加や、さまざまな腸管管理製品の承認と発売なども、予測期間に腸管管理システムの市場を強化すると予測されます。

腸管管理システムの市場力学

現在、腸管管理システム市場は、腸管障害を発症しやすい老年人口の負担の増加によって急成長しています。これは、一部の人々は高齢になるにつれて筋力が徐々に低下するためです。加えて、高齢の女性は男性に比べ、偶発的な腸漏れを経験する頻度が高いです。World Ageing Population 2020 Highlightsによると、2020年の世界の65歳以上の人口は約7億2,700万人でした。同レポートはまた、世界の高齢者数は2050年までに2倍の15億人以上に達すると予測しています。さらに、同年の65歳以上の老年人口の約55％を女性が占めていることにも触れています。

さらに、進行した認知症、多発性硬化症、パーキンソン病（PD）、脊髄損傷による神経損傷などの神経疾患の増加も、神経原性腸管機能障害の重大な危険因子であるため、腸管管理システムの需要を増加させる潜在的な要因となる可能性があります。例えば、Multiple Sclerosis International Federation（2020）のデータによると、同年、世界中で約280万人が多発性硬化症を患っていました。

加えて、交通事故、労働災害、転倒などによる外傷の増加も、末梢神経損傷につながる可能性があるため、腸管管理システム製品の需要を高めています。例えば、国際労働機関（ILO）（2022）のデータによると、世界中で年間約3億4,000万件の労働災害が発生しています。

したがって、上記の要因はすべて、世界の腸管管理システム製品の市場を強化すると予測されます。

さらに、腸管管理製品の承認も、今後数年間で腸管管理システム市場を増強する見込みです。例えば、2019年11月22日、Dentsply Sironaは神経因性腸機能障害、便失禁、慢性便秘の患者への使用を意図したNavina Smart SystemとNavina Classic SystemのFDA承認を取得しました。

このように、前述の要因はすべて、腸管管理システム市場を推進すると予測されます。

しかし、腸管管理システムの使用に伴う不快感が、腸管管理システム市場を抑制する可能性が高いです。

前例のないCOVID-19パンデミックにより、市場における腸管管理システム製品の需要は減少しました。これは、世界中の医療システムのガイドラインが、ロックダウン初期にCOVID-19患者の負荷の管理に一時的に全力を注いだため、多くの選択的処置や外来受診が一時的に停止されたためです。さらに、2020年後半には世界中で多数のCOVID-19ワクチンが承認され投与されたため、医療サービスを含むさまざまな領域で活動の再開が大幅に改善され、それによって腸管管理システム市場の健全な回復期への道が開かれました。

腸管管理システム市場のセグメント分析

腸管管理システム製品セグメントでは、予測期間に神経調節デバイスが大きな市場シェアを占める見込みです。これは、脳、脊髄、末梢神経への外傷の症例の増加による神経因性腸管障害の増加によるものです。例えば、Spinal Cord Injuries Australia（2022）によると、同年に1万5,000人以上のオーストラリア人が脊髄損傷とともに生活しており、そのうち46%が自動車乗員やオートバイ、歩行者、ペダル付き自転車、四輪バイクなどの無防備な陸上輸送の利用者が関わる陸上での交通事故によるものであるのに対し、転倒は脊髄損傷の36%に寄与しています。

当レポートでは、世界の腸管管理システム市場について調査分析し、市場規模と予測、促進要因と課題、企業と製品のプロファイルなどを提供しています。

目次

第1章 腸管管理システム市場レポートのイントロダクション

第2章 腸管管理システム市場のエグゼクティブサマリー

  • 調査範囲
  • 市場の概要
  • 競合の評価
  • 財務ベンチマーク

第3章 規制と特許の分析

  • 米国
  • 欧州
  • 日本
  • 中国

第4章 腸管管理システム市場の主な要因の分析

  • 腸管管理システム市場の促進要因
    • 腸疾患を発症しやすい老年人口の増加
    • 腸失禁発症の危険因子の1つである神経障害の拡大
    • 腸疾患管理に関する意識を高める政府の取り組みの増加
    • 神経損傷の増加
  • 腸管管理システム市場の抑制要因と課題
    • 一部の排便管理システムの厳格な規制承認プロセス
    • 腸失禁の非侵襲性の臨床管理に対する患者の選好
  • 腸管管理システム市場の機会
    • 低中所得国における機会
    • 非侵襲性腸管管理デバイスの機会

第5章 腸管管理システムのポーターのファイブフォース分析

第6章 腸管管理システム市場に対するCOVID-19の影響分析

第7章 腸管管理システム市場のレイアウト

  • 製品タイプ別
    • デバイス
    • アクセサリ
  • 患者タイプ別
    • 成人
    • 小児
  • エンドユーザー
    • 病院
    • 外来手術センター
    • 在宅ケア
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋
    • その他の地域

第8章 腸管管理システム：世界の企業シェア分析 - 主要3～5社

第9章 腸管管理システムの企業と製品のプロファイル

  • Medtronic
  • Coloplast Corp
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • ConvaTec Inc.
  • Laborie
  • Consure Medical
  • Axonics, Inc
  • Renew Medical Inc
  • Hollister Incorporated
  • Welland Medical Limited.
  • Wellspect HealthCare (Dentsply Sirona Company)
  • Restech.
  • Bioness, Inc.
  • A.M.I. GmbH
  • ProSys International Ltd
  • Angiplast Pvt Ltd.
  • Marlen Manufacturing & Development Company

第10章 KOLの見解

第11章 プロジェクトのアプローチ

第12章 DelveInsightについて

第13章 免責事項とお問い合わせ

図表

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Bowel Management Systems Market
  • Table 3 Bowel Management Systems Market Analysis in Global (2021-2030)
  • Table 4 Bowel Management Systems Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Bowel Management Systems Market Analysis in Global by Patient Type (2021-2030)
  • Table 6 Bowel Management Systems Market Analysis in Global by End User (2021-2030)
  • Table 7 Bowel Management Systems Market Analysis in Global by Geography (2021-2030)
  • Table 8 Bowel Management Systems Market Analysis in North America (2021-2030)
  • Table 9 Bowel Management Systems Market Analysis in North America by Product Type (2021-2030)
  • Table 10 Bowel Management Systems Market Analysis in North America by Patient Type (2021-2030)
  • Table 11 Bowel Management Systems Market Analysis in North America by End User (2021-2030)
  • Table 12 Bowel Management Systems Market Analysis in North America by Country (2021-2030)
  • Table 13 Bowel Management Systems Market Analysis in the US (2021-2030)
  • Table 14 Bowel Management Systems Market Analysis in Canada (2021-2030)
  • Table 15 Bowel Management Systems Market Analysis in Mexico (2021-2030)
  • Table 16 Bowel Management Systems Market Analysis in Europe (2021-2030)
  • Table 17 Bowel Management Systems Market Analysis in Europe by Product Type (2021-2030)
  • Table 18 Bowel Management Systems Market Analysis in Europe by Patient Type (2021-2030)
  • Table 19 Bowel Management Systems Market Analysis in Europe by End User (2021-2030)
  • Table 20 Bowel Management Systems Market Analysis in Europe by Country (2021-2030)
  • Table 21 Bowel Management Systems Market Analysis in France (2021-2030)
  • Table 22 Bowel Management Systems Market Analysis in Germany (2021-2030)
  • Table 23 Bowel Management Systems Market Analysis in the UK (2021-2030)
  • Table 24 Bowel Management Systems Market Analysis in Italy (2021-2030)
  • Table 25 Bowel Management Systems Market Analysis in Spain (2021-2030)
  • Table 26 Bowel Management Systems Market Analysis in Russia (2021-2030)
  • Table 27 Bowel Management Systems Market Analysis in Rest of Europe (2021-2030)
  • Table 28 Bowel Management Systems Market Analysis in Asia-Pacific (2021-2030)
  • Table 29 Bowel Management Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Table 30 Bowel Management Systems Market Analysis in Asia-Pacific by Patient Type (2021-2030)
  • Table 31 Bowel Management Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Table 32 Bowel Management Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 33 Bowel Management Systems Market Analysis in China (2021-2030)
  • Table 34 Bowel Management Systems Market Analysis in Japan (2021-2030)
  • Table 35 Bowel Management Systems Market Analysis in India (2021-2030)
  • Table 36 Bowel Management Systems Market Analysis in Australia (2021-2030)
  • Table 37 Bowel Management Systems Market Analysis in South Korea (2021-2030)
  • Table 38 Bowel Management Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 39 Bowel Management Systems Market Analysis in Rest of World (2021-2030)
  • Table 40 Bowel Management Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Table 41 Bowel Management Systems Market Analysis in Rest of World by Patient Type (2021-2030)
  • Table 42 Bowel Management Systems Market Analysis in Rest of World by End User (2021-2030)
  • Table 43 Bowel Management Systems Market Analysis in Rest of World by Country (2021-2030)
  • Table 44 Bowel Management Systems Market Analysis in the Middle East (2021-2030)
  • Table 45 Bowel Management Systems Market Analysis in Africa (2021-2030)
  • Table 46 Bowel Management Systems Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Bowel Management Systems Market
  • Figure 3 Bowel Management Systems Market Analysis in Global (2021-2030)
  • Figure 4 Bowel Management Systems Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Bowel Management Systems Market Analysis in Global by Patient Type (2021-2030)
  • Figure 6 Bowel Management Systems Market Analysis in Global by End User (2021-2030)
  • Figure 7 Bowel Management Systems Market Analysis in Global by Geography (2021-2030)
  • Figure 8 Bowel Management Systems Market Analysis in North America (2021-2030)
  • Figure 9 Bowel Management Systems Market Analysis in North America by Product Type (2021-2030)
  • Figure 10 Bowel Management Systems Market Analysis in North America by Patient Type (2021-2030)
  • Figure 11 Bowel Management Systems Market Analysis in North America by End User (2021-2030)
  • Figure 12 Bowel Management Systems Market Analysis in North America by Country (2021-2030)
  • Figure 13 Bowel Management Systems Market Analysis in the US (2021-2030)
  • Figure 14 Bowel Management Systems Market Analysis in Canada (2021-2030)
  • Figure 15 Bowel Management Systems Market Analysis in Mexico (2021-2030)
  • Figure 16 Bowel Management Systems Market Analysis in Europe (2021-2030)
  • Figure 17 Bowel Management Systems Market Analysis in Europe by Product Type (2021-2030)
  • Figure 18 Bowel Management Systems Market Analysis in Europe by Patient Type (2021-2030)
  • Figure 19 Bowel Management Systems Market Analysis in Europe by End User (2021-2030)
  • Figure 20 Bowel Management Systems Market Analysis in Europe by Country (2021-2030)
  • Figure 21 Bowel Management Systems Market Analysis in France (2021-2030)
  • Figure 22 Bowel Management Systems Market Analysis in Germany (2021-2030)
  • Figure 23 Bowel Management Systems Market Analysis in the UK (2021-2030)
  • Figure 24 Bowel Management Systems Market Analysis in Italy (2021-2030)
  • Figure 25 Bowel Management Systems Market Analysis in Spain (2021-2030)
  • Figure 26 Bowel Management Systems Market Analysis in Russia (2021-2030)
  • Figure 27 Bowel Management Systems Market Analysis in Rest of Europe (2021-2030)
  • Figure 28 Bowel Management Systems Market Analysis in Asia-Pacific (2021-2030)
  • Figure 29 Bowel Management Systems Market Analysis in Asia-Pacific by Product Type (2021-2030)
  • Figure 30 Bowel Management Systems Market Analysis in Asia-Pacific by Patient Type (2021-2030)
  • Figure 31 Bowel Management Systems Market Analysis in Asia-Pacific by End User (2021-2030)
  • Figure 32 Bowel Management Systems Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 33 Bowel Management Systems Market Analysis in China (2021-2030)
  • Figure 34 Bowel Management Systems Market Analysis in Japan (2021-2030)
  • Figure 35 Bowel Management Systems Market Analysis in India (2021-2030)
  • Figure 36 Bowel Management Systems Market Analysis in Australia (2021-2030)
  • Figure 37 Bowel Management Systems Market Analysis in South Korea (2021-2030)
  • Figure 38 Bowel Management Systems Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 39 Bowel Management Systems Market Analysis in Rest of World (2021-2030)
  • Figure 40 Bowel Management Systems Market Analysis in Rest of World by Product Type (2021-2030)
  • Figure 41 Bowel Management Systems Market Analysis in Rest of World by Patient Type (2021-2030)
  • Figure 42 Bowel Management Systems Market Analysis in Rest of World by End User (2021-2030)
  • Figure 43 Bowel Management Systems Market Analysis in Rest of World by Country (2021-2030)
  • Figure 44 Bowel Management Systems Market Analysis in the Middle East (2021-2030)
  • Figure 45 Bowel Management Systems Market Analysis in Africa (2021-2030)
  • Figure 46 Bowel Management Systems Market Analysis in South America (2021-2030)
  • Figure 47 Market Drivers
  • Figure 48 Market Barriers
  • Figure 49 Market Opportunities
  • Figure 50 PORTER's Five Force Analysis
目次
Product Code: DIMDCL0318

Bowel Management Systems Market By Product Type ( Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult And Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, And Home Care), and by geography is projected to expand at a noteworthy CAGR forecast till 2030 owing to the growing burden of aging population, worldwide and rising neurological disorders

The global bowel management systems market was valued at USD 1.48 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.87 billion by 2030. The increase in demand for bowel management products is primarily attributed to the increasing geriatric population across the globe who are more susceptible to developing bowel-associated disorders. In addition, rising neurological disorders such as Parkinson's disease, stroke, among others, and growing cases of nerve injuries due to spinal cord injuries, trauma injuries, and others would also increase the demand for bowel management systems as these factors most often lead to bowel incontinences. Also, rising government initiatives to raise awareness regarding prevention and management of bowel control issues, approval and launch of various bowel management products, among others are anticipated to bolster the market for bowel management systems during the forecasted period.

Bowel Management Systems Market Dynamics:

The market for bowel management systems is gaining pace at present due to the rising burden of the geriatric population who are prone to develop bowel disorders. This is because some people gradually lose muscle strength as they age. In addition, older women experience accidental bowel leakage more often as compared to men. According to the World Ageing Population 2020 Highlights, there were about 727 million people aged 65 years or over in the world in 2020. The report also projected the global number of older persons to double reaching over 1.5 billion in 2050. In addition, the report also mentioned that women accounted for about 55% of the older population aged 65 years or over in the same year.

Moreover, an increase in neurological disorders such as advanced dementia, multiple sclerosis, Parkinson's disease (PD), or nerve injuries due to spinal cord injuries, and others could also be potential factors that would increase the demand for bowel management systems as these are the significant risk factors for neurogenic bowel dysfunction. For instance, as per the Multiple Sclerosis International Federation 2020 data, approximately 2.8 million people were living with multiple sclerosis around the globe in the same year.

Additionally, rising cases of traumatic injuries due to road accidents, occupational accidents, and falls, among others could lead to peripheral nerve injuries thereby raising the demand for Bowel Management Systems products. For instance, according to the International Labour Organization (ILO) 2022 data, worldwide, there are approximately 340 million occupational accidents annually.

Hence, all the above-mentioned factors are expected to bolster the global market for Bowel Management Systems products.

Furthermore, approval of bowel management products would also augment the market for bowel management systems in the forthcoming years. For instance, on November 22, 2019, Dentsply Sirona received FDA approval for Navina Smart System and Navina Classic System intended for use in patients with neurogenic bowel dysfunction, fecal incontinence, and chronic constipation.

Thus, all the aforementioned factors are expected to propel the bowel management systems market.

However, the discomfort associated with the use of bowel management systems is likely to impede the market for bowel management systems.

With the unprecedented COVID-19 pandemic the demand for Bowel Management Systems products in the market decreased. This was due to the temporary suspension of numerous elective procedures and outpatient visits as the healthcare system guidelines worldwide temporarily focused all their efforts on the management of COVID-19 patient load during the initial lockdown period. Moreover, owing to the approval and administration of numerous COVID-19 vaccines across the globe in the second half of 2020, there was a significant improvement in the resumption of activities across various domains, including healthcare services, thereby paving the way for a sound period of recovery for the Bowel Management Systems market.

Bowel Management Systems Market Segment Analysis:

Bowel Management Systems Market By Product Type (Devices [Irrigation Systems, Nerve Modulation Devices, Others] Accessories), By Patient Type (Adult and Pediatrics), By End-User (Hospitals, Ambulatory Surgical Centres, and Homecare), and By Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the Bowel Management Systems product segment, the nerve modulation devices are anticipated to hold a significant market share during the forecasted period. This is owing to the increase in neurogenic bowel disorders due to an increase in cases of trauma to the brain, spinal cord, or peripheral nerves. For instance, according to the Spinal Cord Injuries Australia 2022, more than 15,000 Australians were living with a spinal cord injury in the same year out of which 46% are due to land transport crashes involving motor vehicle occupants and unprotected land transport users such as motorcyclists, pedestrians, pedal cyclists and quad bikes whereas falls contribute to 36% of spinal cord injuries.

Furthermore, the rising focus towards R&D activities by the government organization and manufacturing companies for the development of nerve modulation devices for the management of bowel disorders such as irritable bowel syndrome, accidental bowel leakage, and others are projected to contribute to the market growth.

For instance, NICHD (National Institute of Child Health and Human Development) Pelvic Floor Disorders Network has completed a clinical trial in the year 2020 for device ES-130, a neuromodulation device for accidental bowel leakage.

Moreover, an increase in product approval for nerve modulation bowel management devices will contribute to the market growth. For instance, in January 2020, Bioness, Inc., the leading provider of advanced, clinically supported medical devices for the treatment of chronic pain of peripheral nerve origin, received CE mark approval for its StimRouter® Neuromodulation System indicated for the treatment of faecal incontinence (FI) across Europe.

Hence, all the interplay of all the above-mentioned factors will contribute to the segmental growth of the bowel management systems market in the upcoming years.

North America is expected to dominate the overall Bowel Management Systems Market:

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2020 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

The rising prevalence of Parkinson's disease in the region would contribute to the bowel management systems market. This is because faecal incontinence is a very debilitating symptom that can occur in advanced PD thereby leading to an increase in the demand for bowel management products. For instance, as per the Parkinson's Foundation 2022, approximately 1.2 million people in the US are estimated to suffer from Parkinson's disease by the year 2030.

In addition, as per the 2022 data published by Crohn's and Colitis Canada, Persons with Crohn's disease or ulcerative colitis (together, inflammatory bowel disease [IBD]) make up more than 0.75% of the Canadian population in 2022. The disease affects over 300,000 Canadians which is expected to rise to 400,000 (1% of the population) by 2030. Thus, the rising population with bowel dysfunction and neurological disorders who are susceptible to developing bowel disorders would contribute to the growth of the regional bowel management systems market.

Moreover, product approvals in the region for the treatment of bowel discomfort are also expected to bolster the demand for bowel management systems in the country. For instance, on September 06, 2019, Axonics Modulation Technologies, Inc. received FDA clearance for its Axonics Sacral Neuromodulation System indicated for the treatment of chronic faecal incontinence in patients who have failed or are not candidates for other treatments, such as medications or physical therapy.

Further, the Asia Pacific region has future potential for the bowel management systems market. This is predominantly owing to the rising geriatric population, growing patient pool, increase in government initiatives to raise awareness regarding the proper management of bowel-associated disorders, and others. For instance, as per the Continence Foundation of Australia 2022 data, by 2030 over 6.2 million Australians will be affected by bowel or bladder incontinence. Furthermore, the Australian Government supports prevention and management of incontinence through three initiatives: National Continence Program (NCP), Continence Aids Payment Scheme (CAPS), and Stoma Appliance Scheme. In addition, improving healthcare infrastructure, rising disposable income, among others also some of the factors responsible for bowel management systems market growth in the region during the forthcoming years.

Bowel Management Systems Market Key Players:

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

Recent Developmental Activities in the Bowel Management Systems Market:

In October 2022, Laborie Medical Technologies Corp. (Laborie) a specialist medical technology company, acquired Pelvalon, Inc., a privately-held medical device company located in Redwood City, CA which has developed an innovative product called the Eclipse(TM) System, a non-surgical, patient-controlled device for women suffering from faecal incontinence (FI).

In May 2022, Axonics, Inc., a global medical technology company focused on developing and commercializing novel products for the treatment of bladder and bowel dysfunction, received European CE Mark approval for its second-generation Axonics r-SNM® implantable neurostimulator (INS) and wireless patient remote control with SmartMRI(TM) technology.

In August 2020, Medtronic plc received approval from the US FDA for its InterStim(TM) Micro neurostimulator and InterStim(TM) SureScan(TM) MRI leads used for treating overactive bladder (OAB), faecal incontinence (FI), and non-obstructive urinary retention.

Key Takeaways from the Bowel Management Systems Market Report Study

Market size analysis for current market size (2023), and market forecast for 5 years (2024-2030)

The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Bowel Management Systems market.

Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years

Key companies dominating the Global Bowel Management Systems Market.

Various opportunities available for the other competitor in the Bowel Management Systems Market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for Bowel Management Systems market growth in the coming future?

Target Audience who can be benefited from the Bowel Management Systems Market Report Study

Bowel Management Systems providers

Research organizations and consulting companies

Bowel Management Systems-related organization, association, forum, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders in Bowel Management Systems

Various End-users want to know more about the Bowel Management Systems Market and the latest technological developments in the Bowel Management Systems market.

Frequently Asked Questions for the Bowel Management Systems Market:

1. What is Bowel Management Systems?

Bowel incontinence, also known as faecal incontinence is generally the situation when the patient is not able to control bowel movements which results in involuntary loss of solid or liquid stool. The clinical devices used to manage bowel activity are called bowel management systems.

2. What is the market for Global Bowel Management Systems?

The global bowel management systems market was valued at USD 1.48 billion in 2023, growing at a CAGR of 3.98% during the forecast period from 2024 to 2030, in order to reach USD 1.87 billion by 2030.

3. What are the drivers for the Global Bowel Management Systems?

The major factors driving the demand for Bowel Management Systems are the rising cases of nerve injuries, increase in the geriatric population, growing neurological disorders. In addition, rising government initiatives to raise awareness regarding bowel incontinence management and approval and launch of advanced products, among others are expected to drive the market.

4. What are the key players operating in Global Bowel Management Systems?

Some of the key market players operating in the Bowel Management Systems market include Coloplast Corp, Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, ConvaTec Inc., Laborie., Consure Medical, Axonics, Inc., Renew Medical Inc, Hollister Incorporated, Welland Medical Limited., Wellspect HealthCare (Dentsply Sirona Company) Restech., Bioness, Inc., A.M.I. GmbH, ProSys International Ltd, Angiplast Pvt Ltd., Marlen Manufacturing & Development Company., among others.

5. Which region has the highest share in the Bowel Management Systems market?

Among all the regions, North America is expected to occupy a major share in the overall Bowel Management Systems market in the year 2023 and is expected to hold its position during the forecasted period. This domination is due to the rise in the target population in the region. In addition, an increase in neurological conditions, the presence of leading bowel management systems companies, and favourable reimbursement policies, among others are expected to surge the demand for the bowel management systems market.

Table of Contents

1.Bowel Management Systems Market Report Introduction

2.Bowel Management Systems Market Executive summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory and Patent Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Bowel Management Systems Market Key factors analysis

  • 4.1 Bowel Management Systems Market Drivers
    • 4.1.1 The rising geriatric population who are prone to develop bowel disorders
    • 4.1.2 Growing neurological disorders which is one of the risk factors for developing bowel incontinence
    • 4.1.3 Rising government initiatives to raise awareness regarding bowel disorder management
    • 4.1.4 Rising nerve injuries
  • 4.2 Bowel Management Systems Market Restraints and Challenges
    • 4.2.1 The stringent regulatory approval process of some bowel management systems
    • 4.2.2 Patient preference for non-invasive clinical management of bowel incontinence
  • 4.3 Bowel Management Systems Market Opportunities
    • 4.3.1 Opportunities in low- and middle-income nations
    • 4.3.2 Opportunities for non-invasive bowel management devices

5. Bowel Management Systems Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Bowel Management Systems Market

7. Bowel Management Systems Market layout

  • 7.1 By Product Type
    • 7.1.1 Devices
      • 7.1.1.1 Irrigation Systems
      • 7.1.1.2 Nerve Modulation Devices
      • 7.1.1.3 Others
    • 7.1.2 Accessories
  • 7.2 By Patient Type
    • 7.2.1 Adult
    • 7.2.2 Pediatrics
  • 7.3 End-User
    • 7.3.1 Hospitals
    • 7.3.2 Ambulatory Surgical Centres
    • 7.3.3 Home Care
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 North America Bowel Management Systems Market, by Product Type
      • 7.4.1.2 North America Bowel Management Systems Market, by Patient Type
      • 7.4.1.3 North America Bowel Management Systems Market, by End User
      • 7.4.1.4 North America Bowel Management Systems Market, by Country
      • 7.4.1.4.1 United States
      • 7.4.1.4.2 Canada
      • 7.4.1.4.3 Mexico
    • 7.4.2 Europe
      • 7.4.2.1 Europe Bowel Management Systems Market, by Product Type
      • 7.4.2.2 Europe Bowel Management Systems Market, by Patient Type
      • 7.4.2.3 Europe Bowel Management Systems Market, by End User
      • 7.4.2.4 Europe Bowel Management Systems Market, by Country
      • 7.4.2.4.1 France
      • 7.4.2.4.2 Germany
      • 7.4.2.4.3 United Kingdom
      • 7.4.2.4.4 Italy
      • 7.4.2.4.5 Spain
      • 7.4.2.4.6 Russia
      • 7.4.2.4.7 Rest of Europe
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 Asia-Pacific Bowel Management Systems Market, by Product Type
      • 7.4.3.2 Asia-Pacific Bowel Management Systems Market, by Patient Type
      • 7.4.3.3 Asia-Pacific Bowel Management Systems Market, by End User
      • 7.4.3.4 Asia-Pacific Bowel Management Systems Market, by Country
      • 7.4.3.4.1 China
      • 7.4.3.4.2 Japan
      • 7.4.3.4.3 India
      • 7.4.3.4.4 Australia
      • 7.4.3.4.5 South Korea
      • 7.4.3.4.6 Rest of Asia Pacific
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 RoW Bowel Management Systems Market, by Product Type
      • 7.4.4.2 RoW Bowel Management Systems Market, by Patient Type
      • 7.4.4.3 RoW Bowel Management Systems Market, by End User
      • 7.4.4.4 RoW Bowel Management Systems Market, by Region
      • 7.4.4.4.1 Middle East
      • 7.4.4.4.2 Africa
      • 7.4.4.4.3 South America

8. Bowel Management Systems Global Company Share Analysis - Key 3-5 Companies

9. Bowel Management Systems Company and Product Profiles

  • 9.1 Medtronic
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Coloplast Corp
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 B. Braun Melsungen AG
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Becton, Dickinson and Company
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 ConvaTec Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Laborie
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 Consure Medical
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 Axonics, Inc
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 Renew Medical Inc
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Hollister Incorporated
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Welland Medical Limited.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Wellspect HealthCare (Dentsply Sirona Company)
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Restech.
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 Bioness, Inc.
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 A.M.I. GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 ProSys International Ltd
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 Angiplast Pvt Ltd.
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Marlen Manufacturing & Development Company
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us